Profile | Category | ID | Name | p-value | Adjusted p-value | Count | Total |
---|---|---|---|---|---|---|---|
CNA | Disease | ctd:D006949 | Hyperlipidemias | 1.76E-05 | 2.24E-03 | 3 | 13 |
 | Disease | ctd:D009765 | Obesity | 1.98E-03 | 1.21E-02 | 4 | 132 |
 | Disease | ctd:D007333 | Insulin Resistance | 8.96E-03 | 2.42E-02 | 2 | 35 |
 | Disease | ctd:D009369 | Neoplasms | 1.05E-02 | 2.78E-02 | 2 | 38 |
mRNA | Disease | ctd:D002277 | Carcinoma | 1.19E-04 | 1.23E-02 | 8 | 161 |
 | Disease | ctd:D009364 | Neoplasm Recurrence, Local | 1.25E-02 | 4.96E-02 | 3 | 52 |
METH | GO:MF | GO:0008528 | G-protein coupled peptide receptor activity | 4.15E-05 | 1.21E-02 | 7 | 120 |
 | GO:MF | GO:0001653 | peptide receptor activity | 4.86E-05 | 1.21E-02 | 7 | 123 |
 | GO:MF | GO:0004942 | anaphylatoxin receptor activity | 1.78E-04 | 1.78E-02 | 2 | 3 |
 | GO:MF | GO:0004948 | calcitonin receptor activity | 1.78E-04 | 1.78E-02 | 2 | 3 |
 | GO:MF | GO:0004800 | thyroxine 5'-deiodinase activity | 1.78E-04 | 1.78E-02 | 2 | 3 |